A Study to Investigate the Safety and Efficacy of an Anti-IFNγ mAb in Children Affected by Primary Haemophagocytic Lymphohistiocytosis

Posted by & filed under .

The purpose of this study is to assess the safety, tolerability and preliminary efficacy of a new drug aimed at controlling disease activity in patients diagnosed with primary haemophagocytic lymphohistiocytosis. The new drug will be administered on top of a glucocorticosteroid, which is usually part of the current recommended treatment…. Read more »